M&As this week: LabCorp, Katena Products, Compass Health Brands

6 October 2016 (Last Updated October 6th, 2016 18:30)

Shore Capital Partners, a healthcare private equity firm, has sold ClearPath Diagnostics, a laboratory diagnostics service provider, to Laboratory Corporation of America (LabCorp).

Shore Capital Partners, a healthcare private equity firm, has sold ClearPath Diagnostics, a laboratory diagnostics service provider, to Laboratory Corporation of America (LabCorp).

The acquisition will combine the acquirer’s comprehensive women's health service offering with ClearPath’s local expertise to offer best in-class treatment for LabCorp’s obstetric and gynaecology customers.

Winston & Strawn was the legal advisor for the transaction.

"The acquisition enables Compass Health to deliver better value to its customers by offering its products at lower prices."

In a move expand its ophthalmic product portfolio, specialty surgical developer, Katena Products, has acquired Eagle Vision, a dry eye care and punctal plugs products developer based in Chicago, US.

The acquisition is the second important addition to Katena in 2016 and is a part of its strategy to serve its customers better by expanding its existing product lines and through additional acquisitions.

Compass Health Brands, a medical equipment manufacturer based in Ohio, US, has completed the purchase of Garden City Medical, a subsidiary of Invacare Corporation and distributor of single-use products, in a $13.8m cash transaction.

The acquisition enables Compass Health to deliver better value to its customers by offering its products at lower prices.